Updates are available Correction dated 2024-12-11
Click to view Correction: https://doi.org/10.1007/s11920-024-01580-7
-
Authors
Lavender, Isobel
Garden, Grace
Grunstein, Ronald R.
Yee, Brendon J.
Hoyos, Camilla M.
-
Funding
Funding for this research was provided by:
University of Sydney Postgraduate Scholarship
National Health and Medical Research Council-Australian (1197439)
National Heart Foundation Future Leader Fellowship
- License Information
-
More Information
Article History
Accepted: 3 November 2024
First Online: 29 November 2024
Change Date: 11 December 2024
Change Type: Update
Change Details: The original online version of this article was revised: Isobel Lavender and Grace Garden should have been denoted as equally contributing first authors and in Table 2 footnote the legend "T delta-9-tetrahydro-cannabinool" should be "THC delta-9-tetrahydrocannibinol.
Change Date: 11 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11920-024-01580-7
Declarations
:
: CMH is funded by a National Heart Foundation Future Leader Fellowship. RRG (1197439) is funded by a National Health and Medical Research Council-Australian (NHMRC) Investigator Grant. IL was supported by a Barry and Joy Lambert Postgraduate Research Scholarship between 2021–2023.
: RRG has received discounted investigational products from Neurim Pharmaceuticals and received investigational product and matched placebo from Teva Pharmaceutical in unrelated clinical trials. He has received funding for lectures for Pfizer, Teva, Jazz and Eisai in the past 3 years. RRG is a consultant for Eli Lilly. The other authors have no competing interests to disclose. The Woolcock Institute Sleep and Chronobiology Research Group has received research support from Avadel, Nyxoah, Idorsa, ResMed, BOD Australia, and Philips.
